Showing posts with label Bone Mineral Density. Show all posts
Showing posts with label Bone Mineral Density. Show all posts

9/08/2026

New Insights in Diabetes Care: From Molecular Protectors of Vision to the Balance-Boosting Power of Tai Chi

Journal of Diabetes Investigation: Vol. 16, Issue 11 Review

The November 2025 issue of the Journal of Diabetes Investigation highlights key clinical themes focused on multi-organ diabetic complications, innovative molecular markers, and effective therapeutic exercises. Key research areas explore molecular pathways in diabetic retinopathy and gestational diabetes, simple blood-based predictive biomarkers for neuropathy mortality, and the complex links between fatty liver disease and bone health. Additionally, a notable clinical trial highlights the practical role of supervised Tai Chi Chuan in significantly improving balance and reducing fall risks for older adults dealing with both type 2 diabetes and mild cognitive impairment.

Key Takeaways for Patients and Families:

  • Accessible Exercise: Tai Chi is highly effective—even more than standard walking—at protecting older adults with diabetes from dangerous falls and building daily movement confidence.
  • Targeted Future Treatments: Discoveries in microscopic genetic markers (like miR-21-5p, CFL2, and OIP5-AS1) are paving the way for targeted treatments that aim to arrest kidney and eye damage before they progress.
  • Comprehensive Screening: Managing fatty liver and monitoring blood triglyceride levels are vital step-stones to ensuring bone health and avoiding osteoporosis in diabetic patients.
Disclaimer The information presented in this article is provided for informational purposes only. The blog and its author assume no responsibility for the accuracy, safety, completeness, or reliability of the information. Any actions or decisions based on the information in this article are the sole responsibility of the reader.

This article was created with the assistance of AI. Although the content is based on original research articles and other academic sources, errors may be present. Please verify the information using the original articles and consult qualified healthcare professionals for medical advice.
Diabetic Retinopathy

SP1-activated CFL2 Promotes High Glucose-Induced Retinal Pigment Epithelial Cell Injury

Authors: Jinan Xiao, Jingni Yu, Mei Ren

Research Objective: To investigate the role and molecular mechanism of Cofilin-2 (CFL2) in the progression of diabetic retinopathy (DR), specifically focused on how it impacts retinal pigment epithelial (RPE) cells under high-sugar conditions.

Methods: Researchers used a cell model where human retinal pigment epithelial cells (ARPE-19) were cultured in high-glucose (HG) environments to mimic diabetic retinopathy. Cell growth, cell death (apoptosis), cellular stress (oxidative stress and ferroptosis), and inflammation were evaluated under different genetic conditions, including the silencing of CFL2 and knockdown of the transcription factor SP1.

Main Findings: High glucose severely damaged the retinal cells, stopping growth while inducing cell death, oxidative stress, and inflammation. Silencing CFL2 successfully rescued the cells from this glucose-induced damage. The study also revealed that a protein called SP1 binds to CFL2 to increase its expression, and knocking down SP1 protected the cells. Additionally, SP1 knockdown worked by turning down the activity of the AMPK/mTOR pathway, a key cellular signaling system.

Clinical Significance: By identifying the SP1/CFL2 pathway as a driver of high-glucose-induced eye damage, this study highlights a potential new therapeutic target to protect the vision of individuals with diabetic retinopathy.

Key Points for Patients: When blood sugar is high, specific proteins in the eye trigger inflammation and cell damage. Understanding these tiny molecular switches helps scientists develop new, targeted eye drops or therapies to prevent vision loss in the future.

Read the original article: https://doi.org/10.1111/jdi.70144
Fatty Liver & Bone Health

Relationship Between Liver Fibrosis and Femoral Neck Bone Mineral Density in Patients with T2DM and Fatty Liver

Authors: Jie Tao, Lin Wang, Honggang Wang, Juan Tan

Research Objective: To analyze how liver scarring (fibrosis) affects hip bone density (femoral neck BMD) in patients who have both type 2 diabetes and metabolic dysfunction-associated fatty liver disease (MAFLD).

Methods: A retrospective study was conducted on 569 hospitalized patients with both type 2 diabetes and MAFLD. Liver fibrosis was estimated using the Fibrosis-4 (FIB-4) score, and bone density was measured via standard dual-energy X-ray absorptiometry (DXA) scans.

Main Findings: In postmenopausal women and men aged 50 and older, there was a non-linear, "inverted U-shaped" link between liver fibrosis and bone density, with a threshold value of FIB-4 = 2.091. Below this value, mild fibrosis was associated with higher bone density. However, in patients with high triglycerides (1.7 mmol/L or more), liver fibrosis was significantly associated with decreased bone density.

Clinical Significance: High triglycerides represent a major risk factor for osteoporosis in diabetes patients with fatty liver disease. These findings suggest that patients with high triglycerides and fatty liver should be actively screened for bone loss.

Key Points for Patients: Having type 2 diabetes along with fatty liver disease can impact your bone strength, especially if your triglycerides are high. Keeping your blood lipids in a healthy range is important not just for your heart and liver, but also to protect you from bone fractures.

Read the original article: https://doi.org/10.1111/jdi.70129
Gestational Diabetes

NSUN2-Mediated m5C Methylation Modifies Placental Trophoblast Cells in Gestational Diabetes

Authors: Jiujiu Liu, Yingjun Chen, Dapeng Wang, Zhaozhao Li

Research Objective: To investigate how the RNA-modifying enzyme NSUN2 and its chemical modification (m5C methylation) regulate key placental cells (trophoblasts) in gestational diabetes mellitus (GDM).

Methods: The research team examined the expression levels of the NSUN2 gene and evaluated its effects on cell growth, programmed cell death (apoptosis), and cell cleanup processes (autophagy) in a trophoblast cell line (HTR-8/SVneo).

Main Findings: Trophoblast cells exhibited high expression of the NSUN2 gene. The study demonstrated that NSUN2-mediated m5C methylation directly regulates trophoblast cell proliferation, survival, and cellular waste management (autophagy).

Clinical Significance: These molecular insights reveal how high blood sugar during pregnancy alters placental function at an epigenetic level, offering a potential focus for preventing complications related to gestational diabetes.

Key Points for Patients: Gestational diabetes doesn't just affect blood sugar; it changes how cells in the placenta function and grow. Scientists are mapping these changes to find better ways to keep both mom and baby healthy during pregnancy.

Read the original article: https://doi.org/10.1111/jdi.70140
Diabetic Neuropathy

Red Cell Distribution Width and RDW-to-Albumin Ratio as Long-Term Mortality Predictors in Diabetic Neuropathy

Authors: Jui‐Chu Huang, Pey‐Jium Chang, Yi‐Lun Chiang

Research Objective: To evaluate if two simple blood markers—Red Cell Distribution Width (RDW) and the RDW-to-Albumin Ratio (RAR)—can predict long-term all-cause and cardiovascular disease (CVD) death in patients with diabetic neuropathy.

Methods: This long-term study tracked 624 adults aged 40 and older with diabetic neuropathy from the National Health and Nutrition Examination Survey (NHANES, 1999–2019). The predictive accuracy of RDW and RAR was statistically modeled.

Main Findings: Over the follow-up period, each unit increase in RDW raised all-cause mortality by 12% and CVD mortality by 15%. Even more significantly, each unit increase in RAR increased all-cause mortality by 73% and CVD mortality by 93%. Patients in the highest tier of RAR faced nearly 5 times the risk of cardiovascular death compared to those in the lowest tier. RAR proved to be highly accurate in predicting five-year survival rates.

Clinical Significance: RAR is a highly powerful and easily accessible clinical marker that can identify high-risk diabetic neuropathy patients who require intensive cardiovascular protection.

Key Points for Patients: Neuropathy (nerve damage) is a common complication of diabetes. Simple markers in routine blood tests, like the ratio of red blood cell size variation to protein levels, can help your doctor keep a closer eye on your heart health.

Read the original article: https://doi.org/10.1111/jdi.70147
Diabetic Nephropathy

Dysregulation of miR-21-5p in Diabetic Nephropathy and Its Role in Inflammatory Response

Authors: Yujiang Zhang, Qin Deng, Jianping Yi

Research Objective: To investigate the diagnostic potential and biological role of a tiny molecule in the blood, miR-21-5p, in diabetic kidney disease (diabetic nephropathy).

Methods: Blood samples were compared among three groups: 106 patients with type 2 diabetes, 106 with diabetic nephropathy, and 70 healthy controls. Researchers correlated miR-21-5p levels with standard kidney function measurements (eGFR and protein in urine) and studied the molecule in cultured human kidney cells (mesangial cells).

Main Findings: Serum miR-21-5p levels were significantly elevated in patients with diabetic nephropathy and successfully distinguished them from patients with standard diabetes. Higher levels of miR-21-5p correlated with lower kidney function (eGFR) and higher protein loss in urine (UAER). In laboratory experiments, turning off (knocking down) this molecule reduced inflammatory responses and cell overgrowth caused by high glucose.

Clinical Significance: Serum miR-21-5p functions as both a promising diagnostic marker and a potential therapeutic target that, when blocked, might slow down kidney inflammation and damage.

Key Points for Patients: Over time, high blood sugar can damage the kidneys. This study found a specific biomarker in the blood that rises as kidney function declines. Detecting this marker early could help doctors step in before serious kidney damage occurs.

Read the original article: https://doi.org/10.1111/jdi.70098
Diabetic Retinopathy

Dysregulation of lncRNA OIP5-AS1 Affects Vascular Growth in Diabetic Retinopathy

Authors: Ziwen Yin, Jingyun Dong, Yachao Meng, Zhiqiang Yang, Chunhong Zhao, Qiuyun Wu

Research Objective: To evaluate the clinical significance and cellular function of the long non-coding RNA OIP5-AS1 in patients with diabetic retinopathy.

Methods: The study compared OIP5-AS1 levels in 85 healthy controls, 79 patients with type 2 diabetes, and 114 patients with diabetic retinopathy. Its effects on human retinal vascular endothelial cells (HRVECs) under high glucose conditions were examined.

Main Findings: OIP5-AS1 levels were significantly lower in patients with diabetic retinopathy, and its depletion was linked with severe, proliferative eye damage. Under high glucose, retinal vessel cells lost this protective molecule. Restoring OIP5-AS1 levels stopped the abnormal cell growth by interacting with another molecule, miR-181a-5p, which is associated with aging and cell stress pathways.

Clinical Significance: OIP5-AS1 acts as a protective shield against abnormal retinal blood vessel growth in diabetes. Restoring its levels represents a promising strategy to prevent vision loss in diabetic patients.

Key Points for Patients: Diabetic retinopathy causes abnormal blood vessels to grow in the back of the eye. Scientists have identified a protective molecule that drops in patients with this condition. Finding ways to boost this natural protector could help keep eye vessels healthy.

Read the original article: https://doi.org/10.1111/jdi.70091
Clinical Trial / Lifestyle

Effects of Tai Chi Chuan on Balance Function in Older Adults with Type 2 Diabetes and Mild Cognitive Impairment

Authors: Jiawei Qin, Jia Huang, Jue Liu, Yannan Chen, Jia Luo, Liyuan Tao, et al.

Research Objective: To compare the effectiveness of Tai Chi Chuan against fitness walking and educational controls on balance, physical strength, and fall prevention in older adults (60+) with type 2 diabetes and mild cognitive impairment (MCI).

Methods: A rigorous randomized clinical trial assigned 328 older adults in China to three groups: Tai Chi Chuan (60 mins, 3x/week for 24 weeks), fitness walking (same frequency), or educational control. All participants were followed up to 36 weeks. Assessments measured balance, walking while thinking (dual-task tests), standing stability, leg strength, and the actual number of falls.

Main Findings: By week 36, the Tai Chi group showed significantly greater improvements in complex walking balance, single-leg standing time, reach distance, sit-to-stand speed, and overall balance confidence compared to the walking group. Most importantly, the Tai Chi group had significantly fewer total falls over the 36-week trial period.

Clinical Significance: Tai Chi Chuan is superior to simple walking as an exercise intervention to improve coordination and prevent dangerous falls in diabetic seniors dealing with memory or cognitive challenges.

Key Points for Patients: If you or an older loved one is managing both diabetes and mild memory slips, Tai Chi is a highly effective, safe exercise. It outshines standard walking by building double the confidence, strengthening legs, and significantly lowering the risk of accidental falls.

Read the original article: https://doi.org/10.1111/jdi.70138